Report overview
NHS-Fluorescein is an amine-reactive derivative of fluorescein dye that has wide-ranging applications as a label for antibodies and other probes, for use in fluorescence microscopy, flow cytometry and immunofluorescence-based assays such as Western blotting and ELISA. The NHS-ester of fluorescein efficiently labels antibodies and other purified proteins at primary amines (lysine side chains)
This report aims to provide a comprehensive presentation of the global market for Fluorescein-NHS, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorescein-NHS. This report contains market size and forecasts of Fluorescein-NHS in global, including the following market information:
Global Fluorescein-NHS Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Fluorescein-NHS Market Sales, 2018-2023, 2024-2029, (Kilograms)
Global top five Fluorescein-NHS companies in 2022 (%)
The global Fluorescein-NHS market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Mixed Isomer Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fluorescein-NHS include Thermo Fisher, Sigma-Aldrich, BroadPharm, MuseChem, AKos GmbH, Lumiprobe, AHH Chemical co.,lttd, Glentham Life Sciences Ltd. and Chengdu Biocone Biological Technology Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fluorescein-NHS manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fluorescein-NHS Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kilograms)
Global Fluorescein-NHS Market Segment Percentages, by Type, 2022 (%)
Mixed Isomer
Fluorescein-PEG-NHS
Carboxyfluorescein
Global Fluorescein-NHS Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kilograms)
Global Fluorescein-NHS Market Segment Percentages, by Application, 2022 (%)
Protein Labelling & Crosslinking
Fluorescence Microscopy
Flow Cytometry
Global Fluorescein-NHS Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kilograms)
Global Fluorescein-NHS Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fluorescein-NHS revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Fluorescein-NHS revenues share in global market, 2022 (%)
Key companies Fluorescein-NHS sales in global market, 2018-2023 (Estimated), (Kilograms)
Key companies Fluorescein-NHS sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
Sigma-Aldrich
BroadPharm
MuseChem
AKos GmbH
Lumiprobe
AHH Chemical co.,lttd
Glentham Life Sciences Ltd.
Chengdu Biocone Biological Technology Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fluorescein-NHS, market overview.
Chapter 2: Global Fluorescein-NHS market size in revenue and volume.
Chapter 3: Detailed analysis of Fluorescein-NHS manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fluorescein-NHS in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fluorescein-NHS capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
